![Matthew Rotenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Rotenberg
Direktor/Vorstandsmitglied bei Biosimilars Canada
Aktive Positionen von Matthew Rotenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biosimilars Canada
![]() Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Matthew Rotenberg
Ehemalige bekannte Positionen von Matthew Rotenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Fresenius Kabi Canada Ltd.
![]() Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Vorstandsvorsitzender | 01.05.2000 | 01.07.2023 |
Statistik
International
Kanada | 3 |
Operativ
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Fresenius Kabi Canada Ltd.
![]() Fresenius Kabi Canada Ltd. Pharmaceuticals: MajorHealth Technology Fresenius Kabi Canada Ltd. health care services. The firm offers intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parental nutrition, and medical devices. The company was founded in 1999 and is headquartered in Toronto, Canada. | Health Technology |
Biosimilars Canada
![]() Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Commercial Services |
- Börse
- Insiders
- Matthew Rotenberg
- Erfahrung